Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab in Patients With Relapsed or Refractory TTP-HUS
- Status
- UNKNOWN
- Phase
- PHASE2
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
- Status
- TERMINATED
- Phase
- PHASE2
Non-Myeloablative Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
CFAR Study in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)
- Status
- COMPLETED
- Phase
- PHASE2
HD18 for Advanced Stages in Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Rituxan With or Without Methotrexate in Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
FM 140 vs FM100 Study in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and ABVD for Hodgkin's Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability of Rituximab in Neuromyelitis Optica
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18
- Status
- COMPLETED
- Phase
- PHASE1
G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients
- Status
- COMPLETED
- Phase
- PHASE2